Protagonist Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Apr 24 | SellUS$30,986 | Asif Ali | Individual | 1,234 | US$25.11 | |
01 Mar 24 | SellUS$377,725 | Asif Ali | Individual | 12,187 | US$32.33 | |
15 Nov 23 | SellUS$30,012 | Arturo Molina | Individual | 1,848 | US$16.24 |
Insider Trading Volume
Insider Buying: PTGX insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 11,770 | 0.0193% |
Individual Insiders | 810,708 | 1.33% |
Hedge Funds | 16,794,792 | 27.5% |
Institutions | 43,487,942 | 71.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,744,848 | US$148.2m | 0% | 3.44% | |||
5,734,430 | US$147.9m | 5.29% | 1.02% | |||
5,543,902 | US$143.0m | 6.01% | no data | |||
5,315,514 | US$137.1m | -1.85% | 2.36% | |||
3,153,916 | US$81.3m | -2.31% | no data | |||
2,729,929 | US$70.4m | -30.8% | no data | |||
2,613,453 | US$67.4m | 136% | 0.14% | |||
2,449,183 | US$63.2m | 0% | 1.61% | |||
2,004,875 | US$51.7m | 10.2% | 3.81% | |||
1,557,636 | US$40.2m | 0% | 1.45% | |||
1,291,701 | US$33.3m | 84.5% | 0.06% | |||
1,270,561 | US$32.8m | 52.1% | 0.62% | |||
1,248,284 | US$32.2m | 5.67% | no data | |||
1,159,499 | US$29.9m | 189% | no data | |||
910,012 | US$23.5m | 1,170% | 0.01% | |||
823,740 | US$21.2m | -0.99% | no data | |||
816,537 | US$21.1m | -13.3% | no data | |||
715,000 | US$18.4m | -2.43% | 1.6% | |||
550,139 | US$14.2m | -2.23% | no data | |||
538,074 | US$13.9m | 87.7% | 1.14% | |||
537,000 | US$13.8m | -14.8% | 0.04% | |||
513,681 | US$13.2m | 0% | 3.67% | |||
502,892 | US$13.0m | 0% | 27.8% | |||
465,952 | US$12.0m | -8.5% | no data | |||
460,044 | US$11.9m | 85.4% | 4.68% |